Financial reports
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
7 Feb 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
3 Nov 21
Current reports
8-K
Other Events
29 Mar 24
8-K
Other Events
26 Mar 24
8-K
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
5 Mar 24
8-K
Other Events
12 Jan 24
8-K
Termination of a Material Definitive Agreement
11 Jan 24
8-K
Results of Operations and Financial Condition
10 Jan 24
8-K
Entry into a Material Definitive Agreement
7 Dec 23
8-K
Amendments to Articles of Incorporation or Bylaws
1 Dec 23
8-K
Other Events
22 Nov 23
8-K
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7 Nov 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
29 Mar 24
424B5
Prospectus supplement for primary offering
27 Mar 24
S-3
Shelf registration
5 Mar 24
S-8
Registration of securities for employees
5 Mar 24
S-8
Registration of securities for employees
31 Jan 24
424B5
Prospectus supplement for primary offering
12 Jan 24
424B5
Prospectus supplement for primary offering
10 Jan 24
424B5
Prospectus supplement for primary offering
7 Dec 23
424B5
Prospectus supplement for primary offering
20 Jun 23
FWP
Free writing prospectus
15 Jun 23
Proxies
DEF 14A
Definitive proxy
16 Oct 23
PRE 14A
Preliminary proxy
4 Oct 23
DEFA14A
Additional proxy soliciting materials
5 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
23 May 22
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
Other
EFFECT
Notice of effectiveness
13 Mar 24
EFFECT
Notice of effectiveness
10 Feb 23
EFFECT
Notice of effectiveness
19 May 21
EFFECT
Notice of effectiveness
14 May 21
CORRESP
Correspondence with SEC
11 May 21
CORRESP
Correspondence with SEC
11 May 21
UPLOAD
Letter from SEC
19 Mar 21
SEC STAFF
SEC staff action: Order
21 Oct 20
EFFECT
Notice of effectiveness
16 Oct 20
CERT
Certification of approval for exchange listing
15 Oct 20
Ownership
SC 13G/A
Venrock Healthcare Capital Partners III, L.P.
14 Feb 24
4
Lauren Mastrocola
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
4
Alex Nemiroff
14 Feb 24
4
Marcio Souza
14 Feb 24
SC 13G/A
PFM Health Sciences, LP
14 Feb 24
SC 13G/A
Cormorant Asset Management, LP
14 Feb 24
SC 13G/A
EVENTIDE ASSET MANAGEMENT, LLC
14 Feb 24
SC 13G/A
Tri Locum Partners LP
14 Feb 24
SC 13G
Verition Fund Management LLC
14 Feb 24